(Q30308822)

16 June 2017

1 reference

title

Cryptosporidiosis: an update (English)

1 reference

16 June 2017

1 reference

M Kosek

1

0 references

author name string

C Alcantara

series ordinal

2

1 reference

16 June 2017

A A Lima

series ordinal

3

1 reference

16 June 2017

R L Guerrant

series ordinal

4

1 reference

16 June 2017

publication date

1 November 2001

1 reference

Lancet Infectious Diseases

16 June 2017

published in

1 reference

16 June 2017

volume

1

1 reference

16 June 2017

issue

4

1 reference

16 June 2017

page(s)

262-269

1 reference

Cryptosporidium and cryptosporidiosis in man and animals.

16 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900121-9

7 January 2021

Molecular characterization of Cryptosporidium isolates obtained from human immunodeficiency virus-infected individuals living in Switzerland, Kenya, and the United States

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900121-9

7 January 2021

Identification of 5 types of Cryptosporidium parasites in children in Lima, Peru

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900121-9

7 January 2021

New cryptosporidium genotypes in HIV-infected persons

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900121-9

7 January 2021

The infectivity of Cryptosporidium parvum in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900121-9

7 January 2021

Virulence of three distinct Cryptosporidium parvum isolates for healthy adults

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900121-9

7 January 2021

A hospital-based case-control study of stillbirths and environmental exposure to arsenic using an atmospheric dispersion model linked to a geographical information system

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900121-9

7 January 2021

Seroepidemiologic study of Cryptosporidium infection in children from rural communities of Anhui, China and Fortaleza, Brazil

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900121-9

7 January 2021

Asymptomatic and symptomatic cryptosporidiosis: their acute effect on weight gain in Peruvian children

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900121-9

7 January 2021

Genetic polymorphism among Cryptosporidium parvum isolates: evidence of two distinct human transmission cycles

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900121-9

7 January 2021

Genetic characterization of Cryptosporidium strains from 218 patients with diarrhea diagnosed as having sporadic cryptosporidiosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900121-9

7 January 2021

Differentiating human from animal isolates of Cryptosporidium parvum

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900121-9

7 January 2021

An outbreak of cryptosporidiosis linked to a foodhandler

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900121-9

7 January 2021

An outbreak of cryptosporidiosis from fresh-pressed apple cider

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900121-9

7 January 2021

Cryptosporidiosis: an outbreak associated with drinking water despite state-of-the-art water treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900121-9

7 January 2021

An outbreak of waterborne cryptosporidiosis in Swindon and Oxfordshire

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900121-9

7 January 2021

Cryptosporidiosis: an unrecognized cause of diarrhea in elderly hospitalized patients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900121-9

7 January 2021

Massive Outbreak of Waterborne Cryptosporidium Infection in Milwaukee, Wisconsin: Recurrence of Illness and Risk of Secondary Transmission

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900121-9

7 January 2021

Cryptosporidiosis in Wisconsin: a case-control study of post-outbreak transmission

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900121-9

7 January 2021

Longitudinal study of Cryptosporidium infection in children in northeastern Brazil.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900121-9

7 January 2021

Cryptosporidium infection and CD4 counts

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900121-9

7 January 2021

Biliary cryptosporidiosis in HIV-infected people after the waterborne outbreak of cryptosporidiosis in Milwaukee

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900121-9

7 January 2021

Cryptosporidiosis in patients with AIDS: correlates of disease and survival.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900121-9

7 January 2021

Cryptosporidiosis in northeastern Brazilian children: association with increased diarrhea morbidity

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900121-9

7 January 2021

Association of early childhood diarrhea and cryptosporidiosis with impaired physical fitness and cognitive function four-seven years later in a poor urban community in northeast Brazil

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900121-9

7 January 2021

Cryptosporidiosis in infancy and childhood mortality in Guinea Bissau, west Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900121-9

7 January 2021

Cryptosporidiosis among patients infected with human immunodeficiency virus. Factors related to symptomatic infection and survival.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900121-9

7 January 2021

Effect of immune activation induced by Cryptosporidium parvum whole antigen on in vitro human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900121-9

7 January 2021

Intestinal epithelial cell apoptosis following Cryptosporidium parvum infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900121-9

7 January 2021

Cryptosporidium parvum infection of intestinal epithelium: morphologic and functional studies in an in vitro model

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900121-9

7 January 2021

Characterization of an intestinal epithelial cell receptor recognized by the Cryptosporidium parvum sporozoite ligand CSL

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900121-9

7 January 2021

Cryptosporidiosis in the acquired immunodeficiency syndrome: A study of 15 autopsy cases

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900121-9

7 January 2021

Duodenal morphology and intensity of infection in AIDS-related intestinal cryptosporidiosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900121-9

7 January 2021

Human intestinal epithelial cells respond to Cryptosporidium parvum infection with increased prostaglandin H synthase 2 expression and prostaglandin E2 and F2alpha production

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900121-9

7 January 2021

Cryptosporidium parvum infection of human intestinal epithelial cells induces the polarized secretion of C-X-C chemokines

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900121-9

7 January 2021

Infectivity of Cryptosporidium parvum in healthy adults with pre-existing anti-C. parvum serum immunoglobulin G

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900121-9

7 January 2021

Severe, protracted intestinal cryptosporidiosis associated with interferon gamma deficiency: pediatric case report

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900121-9

7 January 2021

Profiles of healing and nonhealing Cryptosporidium parvum infection in C57BL/6 mice with functional B and T lymphocytes: the extent of gamma interferon modulation determines the outcome of infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900121-9

7 January 2021

Interferon-gamma is required for innate immunity to Cryptosporidium parvum in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900121-9

7 January 2021

Interferon‐γ Expression in Jejunal Biopsies in Experimental Human Cryptosporidiosis Correlates with Prior Sensitization and Control of Oocyst Excretion

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900121-9

7 January 2021

Detection of Giardia lamblia, Entamoeba histolytica/Entamoeba dispar, and Cryptosporidium parvum antigens in human fecal specimens using the triage parasite panel enzyme immunoassay

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900121-9

7 January 2021

Detection of Giardia lamblia and Cryptosporidium parvum antigens in human fecal specimens using the ColorPAC combination rapid solid-phase qualitative immunochromatographic assay

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900121-9

7 January 2021

Application of molecular techniques to the diagnosis of microsporidial infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900121-9

7 January 2021

Evaluation of methodologies including immunofluorescent assay (IFA) and the polymerase chain reaction (PCR) for detection of human pathogenic microsporidia in water

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900121-9

7 January 2021

Paromomycin for cryptosporidiosis in AIDS: a prospective, double-blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900121-9

7 January 2021

Prospective trial of paromomycin for cryptosporidiosis in AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900121-9

7 January 2021

Paromomycin: no more effective than placebo for treatment of cryptosporidiosis in patients with advanced human immunodeficiency virus infection. AIDS Clinical Trial Group

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900121-9

7 January 2021

Combination drug therapy for cryptosporidiosis in AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900121-9

7 January 2021

A double-'blind' placebo-controlled study of nitazoxanide in the treatment of cryptosporidial diarrhoea in AIDS patients in Mexico

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900121-9

7 January 2021

Treatment of diarrhea caused by Cryptosporidium parvum: a prospective randomized, double-blind, placebo-controlled study of Nitazoxanide

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900121-9

7 January 2021

Activity of nitazoxanide alone and in combination with azithromycin and rifabutin against Cryptosporidium parvum in cell culture

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900121-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900121-9

7 January 2021

Intestinal protozoa in HIV-infected patients: effect of rifaximin in Cryptosporidium parvum and Blastocystis hominis infections

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900121-9

7 January 2021

Possible Effectiveness of Clarithromycin and Rifabutin for Cryptosporidiosis Chemoprophylaxis in HIV Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900121-9

7 January 2021

Treatment of HIV-1-associated microsporidiosis and cryptosporidiosis with combination antiretroviral therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900121-9

7 January 2021

Effect of antiretroviral therapy on cryptosporidiosis and microsporidiosis in patients infected with human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900121-9

7 January 2021

Glutamine transporter in crypts compensates for loss of villus absorption in bovine cryptosporidiosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900121-9

7 January 2021

Inactivation of Cryptosporidium parvum oocysts with ozone and monochloramine at low temperature

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900121-9

7 January 2021

The effect of temperature on the efficacy of ozonation for inactivating Cryptosporidium parvum oocysts.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900121-9

7 January 2021

Chlorine disinfection of recreational water for Cryptosporidium parvum

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900121-9

7 January 2021

Interaction between Cryptosporidium oocysts and water treatment coagulants

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900121-9

7 January 2021

Inactivation of Cryptosporidium parvum oocysts using medium- and low-pressure ultraviolet radiation

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900121-9

7 January 2021

Monitoring not the answer to cryptosporidium in water

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2801%2900121-9

7 January 2021

10.1016/S1473-3099(01)00121-9

Identifiers

DOI

1 reference

16 June 2017

1 reference